Kestra Medical Technologies revenue was $95.13M for the trailing 12 months ending Apr 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Apr 30, 2026 was $28.6M, up 16.6% from last quarter. For the last reported fiscal year 2026 ending Apr 30, 2026, KMTS annual revenue was $95.1M, with 59% growth year-over-year.
KMTS past revenue growth
How has KMTS's revenue growth performed historically?
Kestra Medical Technologies (NASDAQ: KMTS) reported Q1 2026 revenue of $28.64 million up 66.18% year over year. In the same quarter last year, Kestra Medical Technologies's revenue was $17.23 million.
What was Kestra Medical Technologies's revenue in 2026?
Kestra Medical Technologies's annual revenue for the twelve months ending Apr 30, 2026 was $95.13 million, a 59.03% increase year over year.
How much does Kestra Medical Technologies make in a day?
Based on Kestra Medical Technologies annual revenue for the past three years, KMTS makes an average of $166,899.54 per day.
What was Kestra Medical Technologies's annual revenue growth in the past year?
As of Q3 2026, Kestra Medical Technologies's revenue has grown 59.03% year over year. This is 47.86 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 11.18%. Kestra Medical Technologies's revenue in the past year totaled $95.13 million.
How much does Kestra Medical Technologies make in a year?
Kestra Medical Technologies's revenue by year for the past three years is:
Kestra Medical Technologies's revenue for the twelve months ending Apr 30, 2026 was $95.13 million, a 59.03% increase year over year.
Kestra Medical Technologies's annual revenue for Apr 30, 2025 was $59.82 million, a 115.05% increase from 2024.
Kestra Medical Technologies's annual revenue for 2024 was $27.81 million, a 264.53% increase from 2023.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.